{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:33:33Z","timestamp":1791498813704,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009032","name":"Pfizer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009032","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry Of Health, Sri Lanka"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Comorbid fibromyalgia, in axial spondyloarthritis (axSpA) has been shown to influence disease activity and function, and quality of life. Although several papers exist, there is no comprehensive and robust systematic review to determine the prevalence of fibromyalgia in this patient group. Thus, the aim of the current study was to provide a definitive estimate of prevalence of fibromyalgia in axSpA, and in axSpA sub-classifications. A systematic literature search was conducted in Ovid MEDLINE, EMBASE, Evidence Based Medicine (EBM), and Cochrane Library, updated to April 2020, combining keywords and relevant MeSH headings, to identify papers reporting the prevalence of fibromyalgia in axSpA, or data from which this could be computed. This was then combined in a meta-analysis\u00a0with data from the Scotland Registry for Ankylosing Spondylitis (SIRAS), a national axSpA register in Scotland. Data was pooled using random or fixed effects models where heterogeneity was greater or lesser than 75%. From 3401 manuscripts initially identified, 15 papers were included in the final review, plus SIRAS, giving data from 16 separate sources. The prevalence of fibromyalgia, among a total of 5214 patients, was 16.4% (95% CI 12.3\u201320.5%). Prevalence varied with axSpA sub-classification: ankylosing spondylitis: 13.8% (9.1\u201318.6%); MRI positive non-radiographic axSpA 20.3% (6.5\u201334.1%); and \u2018clinical\u2019 disease: 11.1% (6.0\u201316.2%). Overall, around 1 in 6 patients with axSpA also meet criteria for fibromyalgia. While estimates from individual studies vary, comorbid fibromyalgia represents a considerable burden across all sub-classifications of axSpA. This emphasises that focusing management solely on inflammatory disease in this patient group is unlikely to yield optimal improvements in quality of life.<\/jats:p>","DOI":"10.1007\/s00296-020-04621-5","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T20:03:31Z","timestamp":1592424211000},"page":"1581-1591","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["The prevalence of fibromyalgia in axial spondyloarthritis"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-7591","authenticated-orcid":false,"given":"Gareth T.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhadra","family":"Mallawaarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9438-9640","authenticated-orcid":false,"given":"Joanna","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-3314","authenticated-orcid":false,"given":"Gary J.","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,15]]},"reference":[{"key":"4621_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38:1113\u20131122","journal-title":"J Rheumatol"},{"key":"4621_CR2","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S et al (2017) Co-occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK national register. Arthritis Rheumatol 69:2144\u20132150","journal-title":"Arthritis Rheumatol"},{"key":"4621_CR3","doi-asserted-by":"crossref","unstructured":"Macfarlane GJ, Pathan E, Jones GT, Dean LE (2019) Predicting response to anti-TNF\u03b1 therapy amongst patients with axial spondyloarthritis (axSpA); results from BSRBR-AS. Rheumatology; in press","DOI":"10.1093\/rheumatology\/kez657"},{"key":"4621_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","volume":"57","author":"SJ Duffield","year":"2018","unstructured":"Duffield SJ, Miller N, Zhao S, Goodson NJ (2018) Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 57:1453\u20131460","journal-title":"Rheumatology (Oxford)"},{"key":"4621_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"4621_CR6","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"4621_CR7","doi-asserted-by":"publisher","DOI":"10.20392\/c12g-tj65","volume-title":"Scotland Registry for Ankylosing Spondylitis (SIRAS)\u2014Protocol","author":"GT Jones","year":"2016","unstructured":"Jones GT, Dean LE, Jones EA, MacDonald AG, Marshall D, McEntegart A et al (2016) Scotland Registry for Ankylosing Spondylitis (SIRAS)\u2014Protocol. University of Aberdeen, Aberdeen. https:\/\/doi.org\/10.20392\/c12g-tj65"},{"key":"4621_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"4621_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"C Clopper","year":"1934","unstructured":"Clopper C, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404\u2013413","journal-title":"Biometrika"},{"key":"4621_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"issue":"6 Suppl 63","key":"4621_CR11","first-page":"S33","volume":"28","author":"R Alm\u00f3dovar","year":"2010","unstructured":"Alm\u00f3dovar R, Carmona L, Zarco P, Collantes E, Gonzalez C, Mulero J et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):S33\u2013S39","journal-title":"Clin Exp Rheumatol"},{"key":"4621_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","volume":"150","author":"S Perrot","year":"2010","unstructured":"Perrot S, Bouhassira D, Fermanian J (2010) Development and validation of the fibromyalgia rapid screening tool (FiRST). Pain 150:250\u2013256","journal-title":"Pain"},{"key":"4621_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"A Molt\u00f3","year":"2018","unstructured":"Molt\u00f3 A, Etcheto A, Gossec L, Boudersa N, Claudepierre P, Roux N et al (2018) Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis 77:533\u2013540","journal-title":"Ann Rheum Dis"},{"key":"4621_CR14","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"4621_CR15","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"4621_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160\u2013172","journal-title":"Arthritis Rheum"},{"key":"4621_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62:600\u2013610","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4621_CR18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","volume":"57","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos X, Regel A, Kiltz U, Menne HJ, Dybowski F, Igelmann M et al (2018) Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford) 57:1541\u20131547","journal-title":"Rheumatology (Oxford)"},{"key":"4621_CR19","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3899\/jrheum.130588","volume":"40","author":"D Wallis","year":"2013","unstructured":"Wallis D, Haroon N, Ayearst R, Carty A, Inman RD (2013) Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol 40:2038\u20132041","journal-title":"J Rheumatol"},{"key":"4621_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","volume":"47","author":"A Fan","year":"2017","unstructured":"Fan A, Pereira B, Tournadre A, Tatar Z, Malochet-Guinamand S, Mathieu S et al (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum 47:129\u2013132","journal-title":"Semin Arthritis Rheum"},{"key":"4621_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00296-007-0344-3","volume":"27","author":"V Aloush","year":"2007","unstructured":"Aloush V, Ablin JN, Reitblat T, Caspi D, Elkayam O (2007) Fibromyalgia in women with ankylosing spondylitis. Rheumatol Int 27:865\u2013868","journal-title":"Rheumatol Int"},{"key":"4621_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1590\/S0482-50042010000600005","volume":"50","author":"VF Azevedo","year":"2010","unstructured":"Azevedo VF, Paiva ES, Felippe LR, Moreira RA (2010) Occurrence of fibromyalgia in patients with ankylosing spondylitis. Rev Bras Reumatol 50:646\u2013650","journal-title":"Rev Bras Reumatol"},{"key":"4621_CR23","first-page":"827","volume":"29","author":"S Dermidal","year":"2013","unstructured":"Dermidal S, Cakir T, Tugrul T, Subashi V (2013) Coexisting of fibromyalgia syndrome and ankylosing spondylitis. Acta Medica Mediterranea 29:827\u2013833","journal-title":"Acta Medica Mediterranea"},{"key":"4621_CR24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","volume":"34","author":"S Haliloglu","year":"2014","unstructured":"Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A (2014) Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int 34:1275\u20131280","journal-title":"Rheumatol Int"},{"key":"4621_CR25","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","volume":"34","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, De AR, Carotti M, Gutierrez M, Sarzi-Puttini P, Atzeni F (2014) Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatol Int 34:1103\u20131110","journal-title":"Rheumatol Int"},{"key":"4621_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","volume":"18","author":"N Bello","year":"2016","unstructured":"Bello N, Etcheto A, Beal C, Dougados M, Molt\u00f3 A (2016) Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res Ther 18:42","journal-title":"Arthritis Res Ther"},{"key":"4621_CR27","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3899\/jrheum.160104","volume":"43","author":"J Wach","year":"2016","unstructured":"Wach J, Letroublon MC, Coury F, Tebib JG (2016) Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J Rheumatol 43:2056\u20132063","journal-title":"J Rheumatol"},{"key":"4621_CR28","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1080\/14397595.2017.1367076","volume":"28","author":"S Monti","year":"2018","unstructured":"Monti S, Todoerti M, Codullo V, Favalli EG, Biggioggero M, Becciolini A et al (2018) Prevalence of ankylosing spondylitis disease activity score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors. Mod Rheumatol 28:542\u2013549","journal-title":"Mod Rheumatol"},{"key":"4621_CR29","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/art.38905","volume":"57","author":"GT Jones","year":"2015","unstructured":"Jones GT, Atzeni F, Beasley M, Fl\u00fc\u00df E, Sarzi-Puttini P, Macfarlane GJ (2015) The prevalence of fibromyalgia in the general population\u2014a comparison of the American College of Rheumatology 1990, 2010 and modified 2010 classification criteria. Arthritis Rheumatol 57:568\u2013575","journal-title":"Arthritis Rheumatol"},{"key":"4621_CR30","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/key206","volume":"57","author":"GJ Macfarlane","year":"2018","unstructured":"Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT (2018) Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatology 57:1982\u20131990","journal-title":"Rheumatology"},{"key":"4621_CR31","first-page":"E579","volume":"22","author":"N Ren\u00e7ber","year":"2019","unstructured":"Ren\u00e7ber N, Saglam G, H\u00fcner B, Kuru \u00d6 (2019) Presence of fibromyalgia syndrome and its relationship with clinical parameters in patients with axial spondyloarthritis. Pain Physician 22:E579\u2013E585","journal-title":"Pain Physician"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04621-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04621-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:24:56Z","timestamp":1623713096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04621-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["4621"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04621-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have conflict of interest or relevant disclosures to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the East of Scotland Research Ethics Service (reference: 16\/ES\/0030). Protocol number: 2-001-16. Approval: 07 April 2016.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}